Cinematherapy for Women With Depression and Anxiety
GINEMOTION
GINEMOTION: Cinematherapy for Women With Depression and Anxiety
1 other identifier
interventional
30
1 country
1
Brief Summary
Group cinematherapy program in reducing depressive and anxiety symptoms in women diagnosed with Depressive Disorders and Anxiety Disorders.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 15, 2025
CompletedFirst Submitted
Initial submission to the registry
March 10, 2025
CompletedFirst Posted
Study publicly available on registry
March 19, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 15, 2025
CompletedAugust 12, 2025
March 1, 2025
6 months
March 10, 2025
August 11, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Assessment of change from baseline in anxiety symptoms.
The presence and degree of anxiety will be assessed using the Hamilton Anxiety Rating Scale (HARS). The scale consists of 14 items designed to assess the severity of a patient's anxiety. Each of the 14 items contains a number of symptoms, and each group of symptoms is rated on a scale of zero to four, with four being the most severe. A score of 17 or less indicates mild anxiety severity. A score from 18 to 24 indicates mild to moderate anxiety severity. Lastly, a score of 25 to 30 indicates a moderate to severe anxiety severity.
8 months
Assessment of change from baseline in depression symptoms.
The presence and degree of depression will be assessed using the Hamilton Depression Rating Scale (HDRS). The scale contains 17 items pertaining to symptoms of depression experienced over the past week. A score of 0-7 is generally accepted to be within the normal range (or in clinical remission), while a score of 20 or higher (indicating at least moderate severity) is usually required for entry into a clinical trial.
8 months
Secondary Outcomes (4)
Weight will be collected for all patients.
8 months
Eight will be collected for all patients.
8 months
Body mass index (BMI) will be collected for all patients.
8 months
Heart rate variability (HRV) will be collected for all patients.
8 months
Study Arms (1)
Cinematherapy intervention
EXPERIMENTALCinematherapy intervention
Interventions
Cinematherapy, also known as cinema therapy and movie therapy, involves therapist-directed viewing of movies for specific therapeutic purposes.
Eligibility Criteria
You may qualify if:
- female, aged 18-75 years;
- Diagnosis of Depressive Disorders (unipolar and bipolar) and Anxiety Disorders according to the criteria of the Diagnostic and Statistical Manual of Mental Disorders - Fifth Edition (DSM-5), both new onset in subjects without a previous psychiatric history, and depressive and anxious recurrences;
- Taking psychopharmacological therapy;
- Fluent knowledge of the Italian language;
- Release of a written informed consent, signed by the patient or legal representative and partner.
You may not qualify if:
- Diagnosis of Schizophrenia or other psychotic spectrum disorders;
- Diagnosis of neurological disorders associated with cognitive decline;
- Current abuse of alcohol and psychotropic substances, with the exception of smoking;
- Refusal to sign the informed consent to participate in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Marianna Mazza
Rome, ROMA, 00168, Italy
Study Officials
- PRINCIPAL INVESTIGATOR
Marianna Mazza
Fondazione Policlinico Universitario A. Gemelli, IRCCS
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 10, 2025
First Posted
March 19, 2025
Study Start
January 15, 2025
Primary Completion
July 15, 2025
Study Completion
July 15, 2025
Last Updated
August 12, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share